Base to Base biotech podcast 41: Eyes, mitochondria and a growing hub
LoQus23 Therapeutics nominates first-in-class oral drug candidate for Huntington’s disease
Earendil Labs to collaborate with Sanofi on bispecific antibodies for autoimmune diseases
Insilico Medicine announces $888m collaboration with Servier
Positive phase III results for idiopathic nephrotic syndrome drug
A new era in Alzheimer’s therapy?
China’s first AI drug completes phase III trial
Hopes for anti-ulcer vaccine
Lilly to acquire Adverum Biotechnologies
Advances in cell therapy for Huntington’s disease treatment
Custom-designed receptors boost cancer-fighting T cells
Promise for early Parkinson’s detection analysis